Increased plasma catalytic iron in patients may mediate acute kidney injury and death following cardiac surgery

Kidney International

Volumn 87, Issue 5, 2015, Pages 1046-1054

  Leaf, David E ^a   Rajapurkar, Mohan ^b   Lele, Suhas S ^b   Mukhopadhyay, Banibrata ^b   Rawn, James D ^a   Frendl, Gyorgy ^a   Waikar, Sushrut S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MULJIBHAI PATEL UROLOGICAL HOSPITAL   (India)

Author keywords

acute kidney injury; cardiopulmonary bypass; free hemoglobin; hemolysis

Indexed keywords

CATALYTIC IRON; FERRITIN; HEMOGLOBIN; IRON DERIVATIVE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; UNCLASSIFIED DRUG; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; IRON; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CARDIOPULMONARY BYPASS; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FEMALE; GASTROINTESTINAL HEMORRHAGE; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HEART MUSCLE INJURY; HEART SURGERY; HEART VENTRICLE FIBRILLATION; HUMAN; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MESENTERIC ISCHEMIA; MORTALITY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; RENAL REPLACEMENT THERAPY; RESPIRATORY FAILURE; SEPTIC SHOCK; UPREGULATION; ACID BASE BALANCE; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; BLOOD; EPIDEMIOLOGY; MASSACHUSETTS; METABOLISM; POSTOPERATIVE COMPLICATIONS; STATISTICS AND NUMERICAL DATA; URINE; VERY ELDERLY;

ACID-BASE EQUILIBRIUM; ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; AGED; AGED, 80 AND OVER; BIOMARKERS; BOSTON; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; FEMALE; HEMOGLOBINS; HUMANS; IRON; LIPOCALINS; MALE; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS; RENAL REPLACEMENT THERAPY;

EID: 84929133938     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.374     Document Type: Article

References (40)

1. Halliwell B, Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 1990; 186: 1-85.
2. Jacob AK, Hotchkiss RS, DeMeester SL et al. Endothelial cell apoptosis is accelerated by inorganic iron and heat via an oxygen radical dependent mechanism. Surgery 1997; 122: 243-253; discussion 254.
3. Pepper JR, Mumby S, Gutteridge JM. Transient iron-overload with bleomycin-detectable iron present during cardiopulmonary bypass surgery. Free Radic Res 1994; 21: 53-58.
4. Lele S, Shah S, McCullough PA et al. Serum catalytic iron as a novel biomarker of vascular injury in acute coronary syndromes. EuroIntervention 2009; 5: 336-342.
5. Steen DL, Cannon CP, Lele SS et al. Prognostic evaluation of catalytic iron in patients with acute coronary syndromes. Clin Cardiol 2012; 36: 139-145.
6. Baliga R, Ueda N, Shah SV. Increase in bleomycin-detectable iron in ischaemia/reperfusion injury to rat kidneys. Biochem J 1993; 291: 901-905.
7. Walker PD, Shah SV. Evidence suggesting a role for hydroxyl radical in gentamicin-induced acute renal failure in rats. J Clin Invest 1988; 81: 334-341.
8. Baliga R, Zhang Z, Baliga M et al. In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int 1998; 53: 394-401.
9. Baliga R, Zhang Z, Baliga M et al. Evidence for cytochrome P-450 as a source of catalytic iron in myoglobinuric acute renal failure. Kidney Int 1996; 49: 362-369.
10. Paller MS. Hemoglobin-and myoglobin-induced acute renal failure in rats: role of iron in nephrotoxicity. Am J Physiol 1988; 255: F539-F544.
11. Hanss BG, Valencia SH, Shah SV et al. The iron chelator deferoxamine prevents contrast media induced acute renal failure in the rabbit [Abstract]. J Am Soc Nephrol 1990; 1: 612.
12. Paller MS, Hedlund BE. Role of iron in postischemic renal injury in the rat. Kidney Int 1988; 34: 474-480.
13. Zager RA. Combined mannitol and deferoxamine therapy for myohemoglobinuric renal injury and oxidant tubular stress. Mechanistic and therapeutic implications. J Clin Invest 1992; 90: 711-719.
14. Waikar SS, Liu KD, Chertow GM. Diagnosis, epidemiology and outcomes of acute kidney injury. Clin J Am Soc Nephrol 2008; 3: 844-861.
15. Haase M, Bellomo R, Haase-Fielitz A. Novel biomarkers, oxidative stress, and the role of labile iron toxicity in cardiopulmonary bypass-associated acute kidney injury. J Am Coll Cardiol 2010; 55: 2024-2033.
16. Kanamori Y, Tanabe H, Shimono T et al. [The effects of administration of haptoglobin for hemolysis by extracorporeal circulation]. Rinsho Kyobu Geka 1989; 9: 463-467.
17. Takami Y, Makinouchi K, Nakazawa T et al. Effect of surface roughness on hemolysis in a pivot bearing supported Gyro centrifugal pump (C1E3). Artif Organs 1996; 20: 1155-1161.
18. Tanaka K, Kanamori Y, Sato T et al. Administration of haptoglobin during cardiopulmonary bypass surgery. ASAIO Trans 1991; 37: M482-M483.
19. Akrawinthawong K, Shaw MK, Kachner J et al. Urine catalytic iron and neutrophil gelatinase-associated lipocalin as companion early markers of acute kidney injury after cardiac surgery: a prospective pilot study. Cardiorenal Med 2013; 3: 7-16.
20. Donadee C, Raat NJ, Kanias T et al. Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation 2011; 124: 465-476.
21. Benedetto U, Angeloni E, Luciani R et al. Acute kidney injury after coronary artery bypass grafting: does rhabdomyolysis play a role? J Thorac Cardiovasc Surg 2010; 140: 464-470.
22. El-Abdellati E, Eyselbergs M, Sirimsi H et al. An observational study on rhabdomyolysis in the intensive care unit. Exploring its risk factors and main complication: acute kidney injury. Ann Intensive Care 2013; 3: 8.
23. Sipe DM, Murphy RF. Binding to cellular receptors results in increased iron release from transferrin at mildly acidic pH. J Biol Chem 1991; 266: 8002-8007.
24. Thakurta PG, Choudhury D, Dasgupta R et al. Tertiary structural changes associated with iron binding and release in hen serum transferrin: a crystallographic and spectroscopic study. Biochem Biophys Res Commun 2004; 316: 1124-1131.
25. Vermeulen Windsant IC, Snoeijs MG, Hanssen SJ et al. Hemolysis is associated with acute kidney injury during major aortic surgery. Kidney Int 2010; 77: 913-920.
26. Davis CL, Kausz AT, Zager RA et al. Acute renal failure after cardiopulmonary bypass in related to decreased serum ferritin levels. J Am Soc Nephrol 1999; 10: 2396-2402.
27. Feelders RA, Vreugdenhil G, Eggermont AM et al. Regulation of iron metabolism in the acute-phase response: interferon gamma and tumour necrosis factor alpha induce hypoferraemia, ferritin production and a decrease in circulating transferrin receptors in cancer patients. Eur J Clin Invest 1998; 28: 520-527.
28. Parikh CR, Coca SG, Thiessen-Philbrook H et al. Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol 2011; 22: 1748-1757.
29. Steinberg D. Antioxidants and atherosclerosis. A current assessment. Circulation 1991; 84: 1420-1425.
30. Rajapurkar MM, Shah SV, Lele SS et al. Association of catalytic iron with cardiovascular disease. Am J Cardiol 2012; 109: 438-442.
31. Paraskevaidis IA, Iliodromitis EK, Vlahakos D et al. Deferoxamine infusion during coronary artery bypass grafting ameliorates lipid peroxidation and protects the myocardium against reperfusion injury: immediate and long-term significance. Eur Heart J 2005; 26: 263-270.
32. Ho J, Sibbald WJ, Chin-Yee IH. Effects of storage on efficacy of red cell transfusion: when is it not safe? Crit Care Med 2003; 31: S687-S697.
33. Koch CG, Li L, Sessler DI et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008; 358: 1229-1239.
34. Biemond P, van Eijk HG, Swaak AJ et al. Iron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes. Possible mechanism in inflammation diseases. J Clin Invest 1984; 73: 1576-1579.
35. Tuttle KR, Worrall NK, Dahlstrom LR et al. Predictors of ARF after cardiac surgical procedures. Am J Kidney Dis 2003; 41: 76-83.
36. Lele SS, Mukhopadhyay BN, Mardikar MM et al. Impact of catalytic iron on mortality in patients with acute coronary syndrome exposed to iodinated radiocontrast-The Iscom Study. Am Heart J 2013; 165: 744-751.
37. Waikar SS, Bonventre JV. Creatinine kinetics and the definition of acute kidney injury. J Am Soc Nephrol 2009; 20: 672-679.
38. Fellahi JL, Hedoire F, Le Manach Y et al. Determination of the threshold of cardiac troponin I associated with an adverse postoperative outcome after cardiac surgery: a comparative study between coronary artery bypass graft, valve surgery, and combined cardiac surgery. Crit Care 2007; 11: R106.
39. Thygesen K, Alpert JS, Jaffe AS et al. Third universal definition of myocardial infarction. Eur Heart J 2012; 33: 2551-2567.
40. Rubenfeld GD, Angus DC, Pinsky MR et al. Outcomes research in critical care: results of the American Thoracic Society Critical Care Assembly Workshop on Outcomes Research. The Members of the Outcomes Research Workshop. Am J Respir Crit Care Med 1999; 160: 358-367.